Omeprazole and lansoprazole suspensions for nasogastric administration.
McAndrews
K L
KL
Eastham
J H
JH
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D002626:Chemistry, Pharmaceutical; D004339:Drug Compounding; D006801:Humans; D007441:Intubation, Gastrointestinal; D064747:Lansoprazole; D009853:Omeprazole / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D017693:Sodium Bicarbonate / Q000008:administration & dosage*; D013535:Suspensions
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D013535:Suspensions; D064747:Lansoprazole; D017693:Sodium Bicarbonate; D009853:Omeprazole